Latest On BioXcel Therapeutics, Inc (BTAI):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-29 08:05 EST | News | BioXcel Therapeutics: Serenity III Part 1 Didn't Meet Primary Endpoints, Part 2 Will | N/A |  |
| 2023-05-25 18:49 EST | News | BioXcel trades lower after mixed results for lower dose Igalmi for bipolar agitation | N/A | |
| 2023-05-22 05:35 EST | News | BioXcel Therapeutics: Clinical Trial Milestones Drive Stock But Slow Market Adoption Persists | N/A | |
| 2023-05-11 17:36 EST | News | BioXcel Therapeutics: It Is All About Key Upcoming Clinical Data Readouts | N/A | |
| 2023-05-08 21:53 EST | News | BioXcel Therapeutics, Inc. (BTAI) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-08 21:53 EST | News | BioXcel closes up 14% despite lackluster quarterly report | N/A | |
| 2023-05-08 08:36 EST | News | BioXcel Therapeutics GAAP EPS of -$1.84 misses by $0.18, revenue of $0.21M misses by $0.11M | N/A | |
| 2023-05-06 00:52 EST | News | BioXcel Therapeutics Q1 2023 Earnings Preview | N/A | |
| 2023-04-27 03:44 EST | News | BioXcel Therapeutics: All Eyes On Igalmi's Ramp, Reiterating Hold Rating | N/A | |
| 2023-04-05 20:01 EST | News | Slow Adoption: BioXcel's Igalmi Struggles To Gain Traction | N/A | |
| 2023-03-17 06:34 EST | News | BioXcel Therapeutics' Igalmi Commercial Launch: Not As Bad As Some May Think | N/A | |
| 2023-03-10 21:07 EST | News | BioXcel cut to Hold at Jefferies on uncertain commercial opportunity | N/A | |
| 2023-03-09 14:10 EST | News | BioXcel Therapeutics GAAP EPS of -$1.95 misses by $0.51, revenue of $0.24M misses by $0.84M | N/A | |
| 2023-03-09 14:10 EST | News | BioXcel Therapeutics, Inc. (BTAI) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-17 14:22 EST | News | BioXcel BXCL701: Another Step Forward In The Race For An mCRPC Treatment | N/A | |
| 2023-01-31 13:28 EST | News | Karuna appoints former BioXcel exec as chief commercial officer | N/A | |
| 2023-01-31 13:28 EST | News | BioXcel Therapeutics: IGALMI Is Likely A Dud In The Real-World | N/A | |
| 2023-01-30 12:10 EST | News | BioXcel Therapeutics: Boldly Entering The Danger Zone With Launch Of IGALMI | N/A | |
| 2023-01-11 08:28 EST | News | BioXcel's BXCL701, Keytruda combo shows promise in mid-stage trial for prostate cancer | N/A | |
| 2022-12-02 02:43 EST | News | BioXcel upgraded at Goldman Sachs on recent underperformance | N/A | |
| 2022-11-30 14:45 EST | News | BioXcel starts dosing in trial of BXCL501 to treat agitation in bipolar, schizophrenia | N/A | |
| 2022-11-14 23:39 EST | News | Seeking Treatment For Agitation In Alzheimer's Patients: A Race For A Multi-Billion Opportunity, And BioXcel's BXCL501 Has The Edge | N/A | |
| 2022-11-11 07:18 EST | News | BioXcel Therapeutics, Inc. (BTAI) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-10 14:14 EST | News | BioXcel Therapeutics GAAP EPS of -$1.49 misses by $0.15, revenue of $0.14M | N/A | |
| 2022-11-10 14:14 EST | News | BioXcel stock soars 17% as lead drug Igalmi starts to bring in revenue | N/A | |
| 2022-11-09 21:36 EST | News | BioXcel Therapeutics Q3 2022 Earnings Preview | N/A | |
| 2022-08-28 18:48 EST | News | BioXcel Therapeutics: Igalmi's Commercial Uncertainty Remains, Downgrading To A Hold | N/A | |
| 2022-08-09 20:06 EST | News | BioXcel Therapeutics GAAP EPS of -$1.35 misses by $0.12 | N/A | |
| 2022-08-09 20:06 EST | News | BioXcel Therapeutics, Inc. (BTAI) CEO Vimal Mehta on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-09 20:06 EST | News | BioXcel stock falls ~9% as Q2 net loss widens | N/A | |
| 2022-08-08 23:15 EST | News | BioXcel Therapeutics Q2 2022 Earnings Preview | N/A | |
| 2022-07-19 14:26 EST | News | BioXcel Therapeutics: BXCL501 For Acute Agitation In Patients With Dementia And Alzheimer's - A Great Asset | N/A | |
| 2022-05-18 23:53 EST | News | BioXcel's Igalmi: Potential Market For Acute Agitation In Esquizofrenia And Bipolar Patients | N/A | |
| 2022-05-10 03:12 EST | News | BioXcel stock falls as Q1 net loss widens Y/Y but Igalmi approval positions to "realize" FY22 goals | N/A | |
| 2022-05-10 03:12 EST | News | BioXcel Therapeutics (BTAI) CEO, Vimal Mehta on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-09 07:21 EST | News | BioXcel Therapeutics GAAP EPS of -$1.12 beats by $0.01 | N/A | |
| 2022-04-19 20:02 EST | News | BioXcel Therapeutics rises after announcing $260M strategic financing, formation of new unit | N/A | |
| 2022-04-09 04:56 EST | News | BioXcel Therapeutics: At A Turning Point After The Approval Of BXCL501 | N/A | |
| 2022-04-06 13:08 EST | News | BioXcel soars on FDA approval for psychiatric therapy | N/A | |
| 2022-04-06 13:08 EST | News | BioXcel price target raised at BofA after FDA approval for Igalmi | N/A | |
| 2022-03-25 16:20 EST | News | BioXcel rises 15% ahead of early April FDA decision on agitation drug BXCL501 | N/A | |
| 2022-03-22 19:29 EST | News | BioXcel Therapeutics Inc.: Speculative Buy To Play The PDUFA For BXCL501 In April | N/A | |
| 2022-03-11 08:26 EST | News | BioXcel Therapeutics, Inc. (BTAI) CEO Vimal Mehta on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-10 13:20 EST | News | BioXcel Therapeutics GAAP EPS of -$0.93 beats by $0.21 | N/A | |
| 2022-03-10 13:20 EST | News | BioXcel Therapeutics down 6% even with bottom line beat | N/A | |
| 2022-03-05 13:07 EST | News | Bioxcel Therapeutics: What To Expect From The Upcoming PDFA | N/A | |
| 2022-02-26 00:37 EST | News | BioXcel Therapeutics (BTAI) Presents At Global Healthcare Virtual Conference - Slideshow | N/A | |
| 2022-02-22 19:58 EST | News | BioXCel agitation with bipolar drug meets primary and secondary endpoints in phase 3 | N/A | |
| 2022-01-26 18:55 EST | News | BioXcel Therapeutics: Facing An Important PDUFA Date In A Few Weeks | N/A | |
| 2021-12-08 03:29 EST | News | BioXcel: Slump After PDUFA Extension Presents Buying Opportunity | N/A | |
About BioXcel Therapeutics, Inc (BTAI):
BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on artificial intelligence-based drug development in the fields of neuroscience and immuno-oncology in the United States. The company is involved in developing BXCL501, a sublingual thin film formulation of adrenergic receptor agonist dexmedetomidine for the treatment of agitation resulting from neurological and psychiatric disorders; and BXCL701, an immune activator for the treatment of prostate and pancreatic cancers, and solid tumors. BioXcel Therapeutics, Inc. has a collaboration with collaboration with the VA Connecticut Healthcare System and the Yale University Medical School for patients suffering from post-traumatic stress disorder related to alcohol and substance abuse disorder. The company was incorporated in 2017 and is headquartered in New Haven, Connecticut.
General
- Name BioXcel Therapeutics, Inc
- Symbol BTAI
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 50
- Fiscal Year EndDecember
- IPO Date2018-03-08
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.bioxceltherapeutics.com
View More
Valuation
- Price/Book (Most Recent Quarter) 5.57
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$4.41
- Next Year EPS Estimate -$3.44
- Next Quarter EPS Estimate -$0.98
- Return on Assets -40%
- Return on Equity -70%
- Earnings Per Share -$1.77
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 1.08 billion
- EBITDA -28411000
- PE Ratio -0.56
- Analyst Target Price $113.36
- Book Value Per Share $8.47
View More
Share Statistics
- Shares Outstanding 24.57 million
- Shares Float 15.26 million
- % Held by Insiders 3980%
- % Held by Institutions 53.92%
- Shares Short 3.61 million
- Shares Short Prior Month 3.57 million
- Short Ratio 6.51
- Short % of Float 25%
- Short % of Shares Outstanding 15%
View More
Technicals
- Beta 1.31
- 52 Week High $67.74
- 52 Week Low $14.27
- 50 Day Moving Average 52.38
- 200 Day Moving Average 49.13
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
BioXcel Therapeutics, Inc (BTAI) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
BioXcel Therapeutics, Inc (BTAI) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-11 | $N/A | -$0.87 | -$0.91 | 4.78% |
| 2020-09-30 | 2020-11-12 | $N/A | -$1.07 | -$0.79 | -35.44% |
| 2020-06-30 | 2020-08-14 | $N/A | -$1.06 | -$0.78 | -35.32% |
| 2020-03-31 | 2020-05-12 | $N/A | -$0.79 | -$0.61 | -29.93% |
| 2019-12-31 | 2020-03-09 | $N/A | -$0.45 | -$0.69 | 34.55% |
| 2019-09-30 | 2019-11-14 | $N/A | -$0.57 | -$0.60 | 5% |
| 2019-06-30 | 2019-08-06 | $N/A | -$0.54 | -$0.60 | 10.54% |
| 2019-03-31 | 2019-05-07 | $N/A | -$0.46 | -$0.53 | 13.37% |
| 2018-12-31 | 2019-03-07 | $N/A | -$0.46 | -$0.37 | -23.03% |
| 2018-09-30 | 2018-11-09 | $N/A | -$0.31 | -$0.29 | -7.53% |
| 2018-06-30 | 2018-08-08 | $N/A | -$0.19 | -$0.31 | 37.91% |
| 2018-03-31 | 2018-05-14 | $N/A | -$0.37 | -$0.27 | -38.99% |
BioXcel Therapeutics, Inc (BTAI) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
BioXcel Therapeutics, Inc (BTAI) Chart:
BioXcel Therapeutics, Inc (BTAI) News:
Below you will find a list of latest news for BioXcel Therapeutics, Inc (BTAI) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
BioXcel Therapeutics, Inc (BTAI) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 0.5 | 2.9 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-05-17 | 1 | 1.65 | CALL | 0 | 107 | 0 | TRUE | 0 | 0 |
| 2024-05-17 | 1.5 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-05-17 | 2 | 0.6 | CALL | 1 | 3 | 194.66 | TRUE | 0.6 | 0 |
| 2024-05-17 | 2.5 | 0.3 | CALL | 0 | 102 | 0 | TRUE | 0 | 0 |
| 2024-05-17 | 3 | 0.13 | CALL | 120 | 839 | 105 | FALSE | -0.02 | -0.13 |
| 2024-05-17 | 3.5 | 0.1 | CALL | 0 | 263 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 4 | 0.09 | CALL | 0 | 441 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 4.5 | 0.05 | CALL | 0 | 53 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 5 | 0.05 | CALL | 0 | 1105 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 5.5 | 0.05 | CALL | 0 | 45 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 7.5 | 0.15 | CALL | 0 | 201 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 0.5 | 0.05 | PUT | 0 | 10 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 1 | 0.16 | PUT | 0 | 2 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 1.5 | 0.4 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2 | 0.05 | PUT | 5 | 38 | 111.51 | FALSE | 0 | 0 |
| 2024-05-17 | 2.5 | 0.25 | PUT | 2 | 313 | 125.34 | FALSE | 0.1 | 0.67 |
| 2024-05-17 | 3 | 0.63 | PUT | 0 | 229 | 131.77 | TRUE | 0 | 0 |
| 2024-05-17 | 3.5 | 1.03 | PUT | 0 | 336 | 145.57 | TRUE | 0 | 0 |
| 2024-05-17 | 4 | 1.56 | PUT | 0 | 126 | 251.64 | TRUE | 0 | 0 |
| 2024-05-17 | 4.5 | 1.7 | PUT | 0 | 24 | 294.13 | TRUE | 0 | 0 |
| 2024-05-17 | 5 | 2.97 | PUT | 0 | 7 | 298.16 | TRUE | 0 | 0 |
| 2024-05-17 | 5.5 | 0 | PUT | 0 | 0 | 296.39 | TRUE | 0 | 0 |
| 2024-05-17 | 7.5 | 5.1 | PUT | 0 | 10 | 319.68 | TRUE | 0 | 0 |
| 2024-06-21 | 0.5 | 0 | CALL | 0 | 0 | 722.78 | TRUE | 0 | 0 |
| 2024-06-21 | 1 | 0 | CALL | 0 | 0 | 564.68 | TRUE | 0 | 0 |
| 2024-06-21 | 1.5 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-06-21 | 2 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-06-21 | 2.5 | 0 | CALL | 0 | 0 | 460.01 | TRUE | 0 | 0 |
| 2024-06-21 | 3 | 0 | CALL | 0 | 0 | 81.32 | FALSE | 0 | 0 |
| 2024-06-21 | 3.5 | 0 | CALL | 0 | 0 | 117.98 | FALSE | 0 | 0 |
| 2024-06-21 | 4 | 0.2 | CALL | 0 | 15 | 147.82 | FALSE | 0 | 0 |
| 2024-06-21 | 4.5 | 0.11 | CALL | 0 | 72 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 5 | 0.15 | CALL | 0 | 66 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 5.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 1.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 2 | 0 | PUT | 0 | 0 | 142.46 | FALSE | 0 | 0 |
| 2024-06-21 | 2.5 | 0.3 | PUT | 0 | 80 | 149.65 | FALSE | 0 | 0 |
| 2024-06-21 | 3 | 0.85 | PUT | 0 | 70 | 416.53 | TRUE | 0 | 0 |
| 2024-06-21 | 3.5 | 0 | PUT | 0 | 0 | 133.39 | TRUE | 0 | 0 |
| 2024-06-21 | 4 | 0 | PUT | 0 | 0 | 202.12 | TRUE | 0 | 0 |
| 2024-06-21 | 4.5 | 0 | PUT | 0 | 0 | 353.08 | TRUE | 0 | 0 |
| 2024-06-21 | 5 | 0 | PUT | 0 | 0 | 194.27 | TRUE | 0 | 0 |
| 2024-06-21 | 5.5 | 0 | PUT | 0 | 0 | 186.99 | TRUE | 0 | 0 |
| 2024-08-16 | 0.5 | 0 | CALL | 0 | 0 | 940.21 | TRUE | 0 | 0 |
| 2024-08-16 | 1 | 2.1 | CALL | 0 | 100 | 460.43 | TRUE | 0 | 0 |
| 2024-08-16 | 1.5 | 1.5 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-08-16 | 2 | 0.7 | CALL | 0 | 1 | 362.79 | TRUE | 0 | 0 |
| 2024-08-16 | 2.5 | 0.5 | CALL | 5 | 60 | 75.57 | TRUE | 0.5 | 0 |
| 2024-08-16 | 3 | 0.4 | CALL | 16 | 267 | 91.19 | FALSE | -0.05 | -0.11 |
| 2024-08-16 | 3.5 | 0.5 | CALL | 0 | 268 | 91.54 | FALSE | 0 | 0 |
| 2024-08-16 | 4 | 0.3 | CALL | 0 | 93 | 93.84 | FALSE | 0 | 0 |
| 2024-08-16 | 4.5 | 0.6 | CALL | 0 | 2 | 171.28 | FALSE | 0 | 0 |
| 2024-08-16 | 5 | 0.4 | CALL | 0 | 309 | 117.99 | FALSE | 0 | 0 |
| 2024-08-16 | 5.5 | 0.2 | CALL | 0 | 98 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 7.5 | 0.1 | CALL | 0 | 110 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 1 | 0.05 | PUT | 0 | 5 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 1.5 | 0.2 | PUT | 0 | 43 | 124.36 | FALSE | 0 | 0 |
| 2024-08-16 | 2 | 0.35 | PUT | 0 | 151 | 131.02 | FALSE | 0 | 0 |
| 2024-08-16 | 2.5 | 0.55 | PUT | 0 | 375 | 121.79 | FALSE | 0 | 0 |
| 2024-08-16 | 3 | 0.95 | PUT | 0 | 656 | 135.45 | TRUE | 0 | 0 |
| 2024-08-16 | 3.5 | 1.57 | PUT | 0 | 6 | 158.63 | TRUE | 0 | 0 |
| 2024-08-16 | 4 | 1.45 | PUT | 0 | 1 | 351.1 | TRUE | 0 | 0 |
| 2024-08-16 | 4.5 | 2.05 | PUT | 0 | 1 | 311.25 | TRUE | 0 | 0 |
| 2024-08-16 | 5 | 2.74 | PUT | 0 | 5 | 156.04 | TRUE | 0 | 0 |
| 2024-08-16 | 5.5 | 0 | PUT | 0 | 0 | 171.63 | TRUE | 0 | 0 |
| 2024-08-16 | 7.5 | 5.1 | PUT | 0 | 11 | 185.99 | TRUE | 0 | 0 |
| 2024-11-15 | 0.5 | 0 | CALL | 0 | 0 | 697.69 | TRUE | 0 | 0 |
| 2024-11-15 | 1.5 | 0 | CALL | 0 | 0 | 375.69 | TRUE | 0 | 0 |
| 2024-11-15 | 2 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-11-15 | 2.5 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-11-15 | 3 | 0 | CALL | 0 | 0 | 297.8 | FALSE | 0 | 0 |
| 2024-11-15 | 3.5 | 0.7 | CALL | 0 | 3 | 99.23 | FALSE | 0 | 0 |
| 2024-11-15 | 4 | 0.4 | CALL | 0 | 81 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 4.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 5 | 0 | CALL | 0 | 0 | 86.62 | FALSE | 0 | 0 |
| 2024-11-15 | 5.5 | 0 | CALL | 0 | 0 | 97.71 | FALSE | 0 | 0 |
| 2024-11-15 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 1.5 | 0 | PUT | 0 | 0 | 141.35 | FALSE | 0 | 0 |
| 2024-11-15 | 2 | 0.6 | PUT | 0 | 4 | 129.45 | FALSE | 0 | 0 |
| 2024-11-15 | 2.5 | 0 | PUT | 0 | 0 | 129.1 | FALSE | 0 | 0 |
| 2024-11-15 | 3 | 0 | PUT | 0 | 0 | 126.99 | TRUE | 0 | 0 |
| 2024-11-15 | 3.5 | 0 | PUT | 0 | 0 | 131.09 | TRUE | 0 | 0 |
| 2024-11-15 | 4 | 0 | PUT | 0 | 0 | 145.1 | TRUE | 0 | 0 |
| 2024-11-15 | 4.5 | 0 | PUT | 0 | 0 | 140.52 | TRUE | 0 | 0 |
| 2024-11-15 | 5 | 3.27 | PUT | 0 | 2 | 103.14 | TRUE | 0 | 0 |
| 2024-11-15 | 5.5 | 0 | PUT | 0 | 0 | 165.83 | TRUE | 0 | 0 |
| 2025-01-17 | 0.5 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-01-17 | 1 | 0 | CALL | 0 | 0 | 638.7 | TRUE | 0 | 0 |
| 2025-01-17 | 1.5 | 1.53 | CALL | 0 | 20 | 142.16 | TRUE | 0 | 0 |
| 2025-01-17 | 2 | 1.29 | CALL | 0 | 151 | 311.42 | TRUE | 0 | 0 |
| 2025-01-17 | 2.5 | 0.9 | CALL | 1 | 0 | 95.47 | TRUE | 0.9 | 0 |
| 2025-01-17 | 3 | 0.91 | CALL | 0 | 10 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 3.5 | 0.75 | CALL | 0 | 71 | 114.25 | FALSE | 0 | 0 |
| 2025-01-17 | 4 | 0.7 | CALL | 0 | 120 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 4.5 | 0.5 | CALL | 0 | 170 | 83.49 | FALSE | 0 | 0 |
| 2025-01-17 | 5 | 0.5 | CALL | 0 | 349 | 94.11 | FALSE | 0 | 0 |
| 2025-01-17 | 5.5 | 0.33 | CALL | 0 | 30 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 7.5 | 0.46 | CALL | 0 | 31 | 114.06 | FALSE | 0 | 0 |
| 2025-01-17 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 1 | 0.4 | PUT | 0 | 0 | 149.58 | FALSE | 0 | 0 |
| 2025-01-17 | 1.5 | 0.5 | PUT | 0 | 7 | 114.5 | FALSE | 0 | 0 |
| 2025-01-17 | 2 | 0.67 | PUT | 0 | 25 | 118.25 | FALSE | 0 | 0 |
| 2025-01-17 | 2.5 | 1.03 | PUT | 0 | 51 | 127.67 | FALSE | 0 | 0 |
| 2025-01-17 | 3 | 1.2 | PUT | 0 | 7 | 140.58 | TRUE | 0 | 0 |
| 2025-01-17 | 3.5 | 0 | PUT | 0 | 0 | 134.18 | TRUE | 0 | 0 |
| 2025-01-17 | 4 | 2.1 | PUT | 0 | 5 | 57.43 | TRUE | 0 | 0 |
| 2025-01-17 | 4.5 | 0 | PUT | 0 | 0 | 90.47 | TRUE | 0 | 0 |
| 2025-01-17 | 5 | 3 | PUT | 0 | 87 | 145.74 | TRUE | 0 | 0 |
| 2025-01-17 | 5.5 | 3.6 | PUT | 0 | 11 | 142.24 | TRUE | 0 | 0 |
| 2025-01-17 | 7.5 | 5.35 | PUT | 0 | 30 | 172.75 | TRUE | 0 | 0 |
| 2026-01-16 | 0.5 | 2.5 | CALL | 0 | 120 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 1 | 3 | CALL | 0 | 1 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 1.5 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 2 | 2.85 | CALL | 0 | 4 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 2.5 | 1.5 | CALL | 0 | 207 | 0 | TRUE | 0 | 0 |
| 2026-01-16 | 3 | 1 | CALL | 1 | 234 | 79.44 | FALSE | 1 | 0 |
| 2026-01-16 | 3.5 | 2.05 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 4 | 1.2 | CALL | 0 | 11 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 4.5 | 1.75 | CALL | 0 | 6 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 5 | 0.75 | CALL | 0 | 36 | 116.89 | FALSE | 0 | 0 |
| 2026-01-16 | 5.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 7.5 | 0.73 | CALL | 0 | 25 | 99.17 | FALSE | 0 | 0 |
| 2026-01-16 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-01-16 | 1 | 0.3 | PUT | 0 | 6 | 165.38 | FALSE | 0 | 0 |
| 2026-01-16 | 1.5 | 0.66 | PUT | 0 | 1 | 116.05 | FALSE | 0 | 0 |
| 2026-01-16 | 2 | 0 | PUT | 0 | 0 | 135.47 | FALSE | 0 | 0 |
| 2026-01-16 | 2.5 | 1.3 | PUT | 0 | 72 | 107.33 | FALSE | 0 | 0 |
| 2026-01-16 | 3 | 1.61 | PUT | 0 | 1 | 125.28 | TRUE | 0 | 0 |
| 2026-01-16 | 3.5 | 0 | PUT | 0 | 0 | 106.48 | TRUE | 0 | 0 |
| 2026-01-16 | 4 | 2.6 | PUT | 0 | 2 | 115.38 | TRUE | 0 | 0 |
| 2026-01-16 | 4.5 | 0 | PUT | 0 | 0 | 91.4 | TRUE | 0 | 0 |
| 2026-01-16 | 5 | 3.1 | PUT | 0 | 25 | 127.64 | TRUE | 0 | 0 |
| 2026-01-16 | 5.5 | 2.6 | PUT | 0 | 3 | 113.57 | TRUE | 0 | 0 |
| 2026-01-16 | 7.5 | 5.31 | PUT | 0 | 4 | 128.7 | TRUE | 0 | 0 |
Latest BTAI Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 100 | $9.23 |
| Jun 13, 2022 7:59 PM EST | 9 | $9.235 |
| Jun 13, 2022 7:59 PM EST | 19 | $9.24 |
| Jun 13, 2022 7:59 PM EST | 41 | $9.25 |
| Jun 13, 2022 7:59 PM EST | 100 | $9.24 |
BioXcel Therapeutics, Inc (BTAI) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465920076490/0001104659-20-076490-index.htm |
| 2019-04-04 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1720893/000000000019006497/0000000000-19-006497-index.htm |
| 2019-01-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1720893/000031506619000020/0000315066-19-000020-index.htm |
| 2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1720893/000031506620000854/0000315066-20-000854-index.htm |
| 2019-04-01 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1720893/000104746919001846/0001047469-19-001846-index.htm |
| 2019-05-20 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1720893/000104746919003199/0001047469-19-003199-index.htm |
| 2019-09-25 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1720893/000104746919005447/0001047469-19-005447-index.htm |
| 2019-09-27 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1720893/000104746919005498/0001047469-19-005498-index.htm |
| 2020-02-19 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1720893/000104746920000943/0001047469-20-000943-index.htm |
| 2020-02-21 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1720893/000104746920000974/0001047469-20-000974-index.htm |
| 2020-07-27 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/1720893/000104746920004257/0001047469-20-004257-index.htm |
| 2020-07-27 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1720893/000104746920004260/0001047469-20-004260-index.htm |
| 2020-07-31 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1720893/000104746920004337/0001047469-20-004337-index.htm |
| 2018-09-14 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1720893/000106299318003740/0001062993-18-003740-index.htm |
| 2020-02-18 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1720893/000106299320001040/0001062993-20-001040-index.htm |
| 2020-02-24 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1720893/000106299320001128/0001062993-20-001128-index.htm |
| 2020-03-06 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1720893/000106299320001271/0001062993-20-001271-index.htm |
| 2018-05-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465918034817/0001104659-18-034817-index.htm |
| 2018-06-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465918038026/0001104659-18-038026-index.htm |
| 2018-06-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465918038902/0001104659-18-038902-index.htm |
| 2018-06-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465918038943/0001104659-18-038943-index.htm |
| 2018-06-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465918042589/0001104659-18-042589-index.htm |
| 2018-07-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465918046760/0001104659-18-046760-index.htm |
| 2018-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465918050492/0001104659-18-050492-index.htm |
| 2018-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1720893/000110465918050505/0001104659-18-050505-index.htm |
| 2018-08-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465918053383/0001104659-18-053383-index.htm |
| 2018-09-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465918058750/0001104659-18-058750-index.htm |
| 2018-10-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465918064487/0001104659-18-064487-index.htm |
| 2018-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465918065994/0001104659-18-065994-index.htm |
| 2018-11-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465918068277/0001104659-18-068277-index.htm |
| 2018-11-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465918070793/0001104659-18-070793-index.htm |
| 2018-11-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465918070795/0001104659-18-070795-index.htm |
| 2018-11-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465918070826/0001104659-18-070826-index.htm |
| 2018-11-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465918070832/0001104659-18-070832-index.htm |
| 2018-11-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465918070875/0001104659-18-070875-index.htm |
| 2018-11-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465918070876/0001104659-18-070876-index.htm |
| 2018-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465918071215/0001104659-18-071215-index.htm |
| 2018-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465918071220/0001104659-18-071220-index.htm |
| 2018-12-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465918071405/0001104659-18-071405-index.htm |
| 2018-12-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465918071465/0001104659-18-071465-index.htm |
| 2018-12-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465918071741/0001104659-18-071741-index.htm |
| 2018-12-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465918071881/0001104659-18-071881-index.htm |
| 2018-12-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465918072470/0001104659-18-072470-index.htm |
| 2018-12-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465918072547/0001104659-18-072547-index.htm |
| 2018-12-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465918073106/0001104659-18-073106-index.htm |
| 2018-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465918074140/0001104659-18-074140-index.htm |
| 2018-12-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465918074908/0001104659-18-074908-index.htm |
| 2019-01-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465919000498/0001104659-19-000498-index.htm |
| 2019-02-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465919005571/0001104659-19-005571-index.htm |
| 2019-02-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465919007130/0001104659-19-007130-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1720893/000110465919008368/0001104659-19-008368-index.htm |
| 2019-03-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465919012477/0001104659-19-012477-index.htm |
| 2019-03-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465919013402/0001104659-19-013402-index.htm |
| 2019-03-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465919013865/0001104659-19-013865-index.htm |
| 2019-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465919014314/0001104659-19-014314-index.htm |
| 2019-03-14 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1720893/000110465919014871/0001104659-19-014871-index.htm |
| 2019-03-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465919015667/0001104659-19-015667-index.htm |
| 2019-03-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465919015669/0001104659-19-015669-index.htm |
| 2019-03-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465919017151/0001104659-19-017151-index.htm |
| 2019-04-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465919018965/0001104659-19-018965-index.htm |
| 2019-04-01 | RW | Registration Withdrawal Request | https://www.sec.gov/Archives/edgar/data/1720893/000110465919019011/0001104659-19-019011-index.htm |
| 2019-04-01 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1720893/000110465919019020/0001104659-19-019020-index.htm |
| 2019-04-02 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1720893/000110465919019027/0001104659-19-019027-index.htm |
| 2019-04-02 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1720893/000110465919019429/0001104659-19-019429-index.htm |
| 2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465919027345/0001104659-19-027345-index.htm |
| 2019-05-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465919030423/0001104659-19-030423-index.htm |
| 2019-05-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465919030429/0001104659-19-030429-index.htm |
| 2019-05-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465919030930/0001104659-19-030930-index.htm |
| 2019-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465919032141/0001104659-19-032141-index.htm |
| 2019-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465919032142/0001104659-19-032142-index.htm |
| 2019-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465919032143/0001104659-19-032143-index.htm |
| 2019-05-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465919032453/0001104659-19-032453-index.htm |
| 2019-06-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465919036496/0001104659-19-036496-index.htm |
| 2019-07-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465919041197/0001104659-19-041197-index.htm |
| 2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465919044148/0001104659-19-044148-index.htm |
| 2019-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465919045930/0001104659-19-045930-index.htm |
| 2019-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465919045931/0001104659-19-045931-index.htm |
| 2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465919046363/0001104659-19-046363-index.htm |
| 2019-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465919046520/0001104659-19-046520-index.htm |
| 2019-08-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465919047150/0001104659-19-047150-index.htm |
| 2019-08-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465919047308/0001104659-19-047308-index.htm |
| 2019-09-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465919051349/0001104659-19-051349-index.htm |
| 2019-09-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465919051834/0001104659-19-051834-index.htm |
| 2019-11-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465919063711/0001104659-19-063711-index.htm |
| 2019-11-26 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1720893/000110465919067684/0001104659-19-067684-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465920003268/0001104659-20-003268-index.htm |
| 2020-02-14 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465920021799/0001104659-20-021799-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465920021807/0001104659-20-021807-index.htm |
| 2020-02-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465920022880/0001104659-20-022880-index.htm |
| 2020-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465920022899/0001104659-20-022899-index.htm |
| 2020-02-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465920023567/0001104659-20-023567-index.htm |
| 2020-03-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465920030473/0001104659-20-030473-index.htm |
| 2020-04-06 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1720893/000110465920043400/0001104659-20-043400-index.htm |
| 2020-04-06 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1720893/000110465920043401/0001104659-20-043401-index.htm |
| 2020-04-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465920046505/0001104659-20-046505-index.htm |
| 2020-04-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465920052445/0001104659-20-052445-index.htm |
| 2020-05-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465920059966/0001104659-20-059966-index.htm |
| 2020-05-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1720893/000110465920061005/0001104659-20-061005-index.htm |
| 2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465920061009/0001104659-20-061009-index.htm |
| 2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465920061013/0001104659-20-061013-index.htm |
| 2020-05-13 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465920061016/0001104659-20-061016-index.htm |
| 2020-05-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465920064759/0001104659-20-064759-index.htm |
| 2020-05-21 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1720893/000110465920064878/0001104659-20-064878-index.htm |
| 2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465920065871/0001104659-20-065871-index.htm |
| 2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465920065873/0001104659-20-065873-index.htm |
| 2020-05-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465920065876/0001104659-20-065876-index.htm |
| 2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465920067050/0001104659-20-067050-index.htm |
| 2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465920067052/0001104659-20-067052-index.htm |
| 2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465920067056/0001104659-20-067056-index.htm |
| 2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465920067057/0001104659-20-067057-index.htm |
| 2020-06-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465920074174/0001104659-20-074174-index.htm |
| 2020-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465920074176/0001104659-20-074176-index.htm |
| 2020-06-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465920076143/0001104659-20-076143-index.htm |
| 2020-06-23 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000110465920076144/0001104659-20-076144-index.htm |
| 2020-06-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465920076490/0001104659-20-076490-index.htm |
| 2020-07-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465920086817/0001104659-20-086817-index.htm |
| 2020-07-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465920089171/0001104659-20-089171-index.htm |
| 2020-08-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000110465920095015/0001104659-20-095015-index.htm |
| 2020-05-04 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1720893/000119248220000311/0001192482-20-000311-index.htm |
| 2018-11-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1720893/000155837018009106/0001558370-18-009106-index.htm |
| 2018-11-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1720893/000155837018009109/0001558370-18-009109-index.htm |
| 2019-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1720893/000155837019001798/0001558370-19-001798-index.htm |
| 2019-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1720893/000155837019004262/0001558370-19-004262-index.htm |
| 2019-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1720893/000155837019007155/0001558370-19-007155-index.htm |
| 2019-11-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1720893/000155837019010995/0001558370-19-010995-index.htm |
| 2020-03-09 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1720893/000155837020002196/0001558370-20-002196-index.htm |
| 2020-05-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1720893/000155837020006435/0001558370-20-006435-index.htm |
| 2020-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1720893/000155837020010611/0001558370-20-010611-index.htm |
| 2019-04-04 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1720893/999999999519000611/9999999995-19-000611-index.htm |
| 2018-12-20 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1720893/999999999718009626/9999999997-18-009626-index.htm |
BioXcel Therapeutics, Inc (BTAI) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of BioXcel Therapeutics, Inc (BTAI). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 3980%Institutional Ownership: 5392%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2018-11-29 | Krishnan Nandabalan | Director | Buy | 1,000.00 | 4.92 | 4,915.00 | 1,000.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918070832/0001104659-18-070832-index.htm |
| 2018-11-30 | Richard I Steinhart | Chief Financial Officer | Buy | 500.00 | 5.00 | 2,500.00 | 1,000.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918070876/0001104659-18-070876-index.htm |
| 2018-11-30 | Vimal Mehta | CEO, President, Secretary | Buy | 300.00 | 5.20 | 1,560.00 | 1,000.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918070826/0001104659-18-070826-index.htm |
| 2018-12-03 | Vimal Mehta | CEO, President, Secretary | Buy | 200.00 | 5.10 | 1,020.00 | 1,200.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918071220/0001104659-18-071220-index.htm |
| 2018-12-03 | Vimal Mehta | CEO, President, Secretary | Buy | 100.00 | 5.13 | 513.00 | 1,300.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918071220/0001104659-18-071220-index.htm |
| 2018-12-03 | Frank Yocca | Chief Scientific Officer | Buy | 450.00 | 5.23 | 2,353.46 | 1,400.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918071465/0001104659-18-071465-index.htm |
| 2018-12-03 | Vimal Mehta | CEO, President, Secretary | Buy | 100.00 | 5.14 | 514.00 | 1,400.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918071220/0001104659-18-071220-index.htm |
| 2018-12-04 | PETER MUELLER | Director | Buy | 1,076.00 | 5.09 | 5,476.84 | 146,594.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918071741/0001104659-18-071741-index.htm |
| 2018-12-04 | PETER MUELLER | Director | Buy | 325.00 | 5.11 | 1,660.75 | 146,919.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918071741/0001104659-18-071741-index.htm |
| 2018-12-04 | PETER MUELLER | Director | Buy | 344.00 | 5.12 | 1,761.28 | 147,263.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918071741/0001104659-18-071741-index.htm |
| 2018-12-04 | PETER MUELLER | Director | Buy | 200.00 | 5.13 | 1,026.00 | 147,463.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918071741/0001104659-18-071741-index.htm |
| 2018-12-04 | PETER MUELLER | Director | Buy | 2,062.00 | 5.15 | 10,619.30 | 149,525.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918071741/0001104659-18-071741-index.htm |
| 2018-12-03 | Richard I Steinhart | Chief Financial Officer | Buy | 500.00 | 5.20 | 2,599.95 | 1,500.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918071215/0001104659-18-071215-index.htm |
| 2018-12-03 | Vimal Mehta | CEO, President, Secretary | Buy | 100.00 | 5.18 | 518.00 | 1,500.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918071220/0001104659-18-071220-index.htm |
| 2018-12-06 | PETER MUELLER | Director | Buy | 1,295.00 | 5.00 | 6,475.00 | 150,820.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918071881/0001104659-18-071881-index.htm |
| 2018-12-06 | PETER MUELLER | Director | Buy | 100.00 | 5.01 | 501.00 | 150,920.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918071881/0001104659-18-071881-index.htm |
| 2018-12-07 | PETER MUELLER | Director | Buy | 495.00 | 5.00 | 2,475.00 | 151,415.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918071881/0001104659-18-071881-index.htm |
| 2018-12-07 | PETER MUELLER | Director | Buy | 6,905.00 | 5.01 | 34,594.05 | 158,320.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918071881/0001104659-18-071881-index.htm |
| 2019-08-21 | PETER MUELLER | Director | Buy | 1,800.00 | 8.42 | 15,156.00 | 160,120.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465919047150/0001104659-19-047150-index.htm |
| 2019-08-22 | PETER MUELLER | Director | Buy | 6,646.00 | 8.83 | 58,684.18 | 166,766.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465919047150/0001104659-19-047150-index.htm |
| 2019-08-23 | PETER MUELLER | Director | Buy | 1,554.00 | 9.34 | 14,514.36 | 168,320.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465919047308/0001104659-19-047308-index.htm |
| 2018-12-04 | Frank Yocca | Chief Scientific Officer | Buy | 450.00 | 5.20 | 2,338.79 | 1,850.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918071465/0001104659-18-071465-index.htm |
| 2018-12-03 | Vimal Mehta | CEO, President, Secretary | Buy | 500.00 | 5.20 | 2,600.00 | 2,000.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918071220/0001104659-18-071220-index.htm |
| 2018-12-04 | Vimal Mehta | CEO, President, Secretary | Buy | 500.00 | 5.09 | 2,545.00 | 2,500.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918071405/0001104659-18-071405-index.htm |
| 2018-11-30 | Vimal Mehta | CEO, President, Secretary | Buy | 300.00 | 5.04 | 1,512.00 | 300.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918070826/0001104659-18-070826-index.htm |
| 2018-12-04 | Vimal Mehta | CEO, President, Secretary | Buy | 500.00 | 5.15 | 2,575.00 | 3,000.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918071405/0001104659-18-071405-index.htm |
| 2018-12-14 | Vimal Mehta | CEO, President, Secretary | Buy | 800.00 | 4.27 | 3,416.00 | 3,800.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918073106/0001104659-18-073106-index.htm |
| 2018-12-14 | Vimal Mehta | CEO, President, Secretary | Buy | 200.00 | 4.32 | 864.00 | 4,000.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918073106/0001104659-18-073106-index.htm |
| 2018-12-14 | Vimal Mehta | CEO, President, Secretary | Buy | 500.00 | 4.48 | 2,240.00 | 4,500.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918073106/0001104659-18-073106-index.htm |
| 2018-12-14 | Vimal Mehta | CEO, President, Secretary | Buy | 400.00 | 4.49 | 1,796.00 | 4,900.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918073106/0001104659-18-073106-index.htm |
| 2018-11-29 | Frank Yocca | Chief Scientific Officer | Buy | 500.00 | 5.02 | 2,511.15 | 500.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918070795/0001104659-18-070795-index.htm |
| 2018-11-29 | Richard I Steinhart | Chief Financial Officer | Buy | 500.00 | 5.00 | 2,500.00 | 500.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918070793/0001104659-18-070793-index.htm |
| 2018-12-14 | Vimal Mehta | CEO, President, Secretary | Buy | 100.00 | 4.50 | 450.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918073106/0001104659-18-073106-index.htm |
| 2018-11-30 | Vimal Mehta | CEO, President, Secretary | Buy | 300.00 | 5.05 | 1,515.00 | 600.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918070826/0001104659-18-070826-index.htm |
| 2019-08-13 | Vimal Mehta | CEO, President & Secretary | Buy | 1,000.00 | 8.75 | 8,750.00 | 6,000.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465919045931/0001104659-19-045931-index.htm |
| 2019-08-14 | Vimal Mehta | CEO, President & Secretary | Buy | 358.00 | 8.44 | 3,021.52 | 6,358.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465919046363/0001104659-19-046363-index.htm |
| 2018-11-30 | Vimal Mehta | CEO, President, Secretary | Buy | 100.00 | 5.17 | 517.00 | 700.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918070826/0001104659-18-070826-index.htm |
| 2019-08-13 | Frank Yocca | Chief Scientific Officer | Buy | 6,547.00 | 8.67 | 56,762.49 | 8,397.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465919045930/0001104659-19-045930-index.htm |
| 2020-02-14 | Frank Yocca | Chief Scientific Officer | Buy | 80,000.00 | 0.41 | 32,800.00 | 88,397.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465920022899/0001104659-20-022899-index.htm |
| 2019-08-15 | Vimal Mehta | CEO, President & Secretary | Buy | 2,625.00 | 8.67 | 22,758.75 | 8,983.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465919046363/0001104659-19-046363-index.htm |
| 2020-02-24 | Krishnan Nandabalan | Director | Sell | 300,000.00 | 30.08 | 9,024,000.00 | 9,180,000.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465920061009/0001104659-20-061009-index.htm |
| 2020-02-24 | Vimal Mehta | CEO, President and Secretary | Sell | 300,000.00 | 30.08 | 9,024,000.00 | 9,180,000.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465920061013/0001104659-20-061013-index.htm |
| 2018-11-30 | Frank Yocca | Chief Scientific Officer | Buy | 450.00 | 5.20 | 2,339.55 | 950.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465918070875/0001104659-18-070875-index.htm |
| 2019-08-16 | Vimal Mehta | CEO, President and Secretary | Buy | 974.00 | 8.89 | 8,658.86 | 9,957.00 | https://www.sec.gov/Archives/edgar/data/1720893/000110465919046520/0001104659-19-046520-index.htm |